Equity Incentive Plan (Tables)

12 Months Ended

Dec. 31, 2023

Schedule of Additional Information on Stock Option Grants And Vesting

The following table summarizes additional information on stock option grants and vesting (in thousands):

	2019 Plan
	Year Ended December 31, 2023		Year Ended December 31, 2022
Total fair value of stock options granted	$	942	$	2,898
Total fair value of options vested		1,835		3,306

Schedule of Black Scholes model for the Private Warrants

The following table summarizes the assumptions used in the valuation models to determine the fair value of awards granted to employees and non-employee directors under the 2019 Plan:

	Year Ended December 31, 2023	Year Ended December 31, 2022
Expected volatility	41.26%	42.78 - 42.90%
Expected term (in years)	6.0	6.0
Dividend yield	0%	0%
Risk free interest rate	3.61%	1.0 - 1.62%

Stock Based Compensation Expense Included In Consolidated Statements of Comprehensive Loss

Stock-based compensation expense is included in the Consolidated Statements of Comprehensive Loss within the following line items (in thousands):

	Year Ended December 31,
	2023		2022
Cost of revenues	$	917	$	1,640
General and administrative		1,727		2,088
Research and development		373		584
Sales and marketing		348		824
Total	$	3,365	$	5,136

R

Restricted Stock Units [Member]

Schedule of RSUs Activity Under 2019 Plan

The following table summarizes the Company’s RSU activity for performance based RSUs awarded to employees and for time-based RSUs granted to non-employee directors under the 2019 Plan:

Description	RSUs Outstanding
Outstanding at December 31, 2022		1,876,669
Granted		792,000
Vested		(190,059	)
Forfeited		(49,321	)
Expired		—
Outstanding at December 31, 2023		2,429,289

2019 Plan [Member]

Schedule of Stock Option Activity Under 2019 Plan

The following table summarizes the Company’s stock option activity under the 2019 Plan:

Description	Options Outstanding			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value (1)
Options outstanding, December 31, 2021		5,093,682		$	8.34		8.4	$	—
Granted		1,135,850			6.00		—		—
Exercised		—			—		—		—
Forfeited		(273,195	)		7.51		—		—
Expired		(198,558	)		8.24		—		—
Options outstanding, December 31, 2022		5,757,779		$	7.92		7.6	$	—
Granted		997,796			1.05		—		—
Exercised		—			—		—		—
Forfeited		(35,791	)		5.07		—		—
Expired		(190,692	)		8.12		—		—
Options outstanding, December 31, 2023		6,529,092		$	6.88		7.1	$	—
Options vested and exercisable, December 31, 2023		4,503,751		$	8.21		6.4	$	—
Options vested and expected to vest, December 31, 2023		6,529,092		$	6.88		7.1	$	—

(1)Aggregate intrinsic value (in thousands) represents the difference between the estimated fair value of the underlying common stock and the exercise price of outstanding, in-the-money options.